ACAD
31.77
-0.01
-0.03%
AEMD
3.87
+0.11
+2.93%
APRI
1.505
-0.076
-4.7785%
ARNA
1.42
-0.03
-2.07%
ATEC
3.55
+0.05
+1.43%
CNAT
5.09
-0.01
-0.20%
CRXM
0.179
0.00
-0.223%
CYTX
1.58
+0.04
+2.60%
DXCM
85.13
+17.52
+25.91%
GNMK
12.75
+0.13
+1.03%
HALO
11.39
-0.47
-3.96%
ILMN
162.57
-0.27
-0.17%
INNV
0.21
0.00
0.00%
INO
6.98
-0.05
-0.71%
ISCO
1.03
+0.01
+0.98%
ISIS
0
0.00
0.00%
LGND
105.62
-0.79
-0.74%
LPTN
2.93
0.00
0.00%
MBVX
3.35
-0.01
-0.29%
MEIP
1.51
+0.04
+2.72%
MNOV
6.22
+0.03
+0.48%
MRTX
5.4
-0.05
-0.92%
MSTX
0.137
-0.003
-1.9313%
NBIX
42.25
+1.14
+2.77%
NUVA
70.35
+0.46
+0.66%
ONCS
1.36
+0.05
+3.82%
ONVO
3.7
+0.03
+0.82%
OREX
3.33
-0.06
-1.77%
OTIC
16.75
+0.15
+0.90%
QDEL
19.93
-0.08
-0.40%
RCPT
0
0.00
0.00%
RGLS
2.45
-0.05
-2.00%
RMD
65.33
+1.07
+1.67%
SCIE
0.002
+0.00
+25.0000%
SPHS
2.88
+0.09
+3.23%
SRNE
5.65
+0.15
+2.73%
TROV
2.4
+0.05
+2.13%
VICL
2.321
+0.011
+0.4935%
ZGNX
10.35
-1.15
-10.00%
ACAD
31.77
-0.01
-0.03%
AEMD
3.87
+0.11
+2.93%
APRI
1.505
-0.076
-4.7785%
ARNA
1.42
-0.03
-2.07%
ATEC
3.55
+0.05
+1.43%
CNAT
5.09
-0.01
-0.20%
CRXM
0.179
0.00
-0.223%
CYTX
1.58
+0.04
+2.60%
DXCM
85.13
+17.52
+25.91%
GNMK
12.75
+0.13
+1.03%
HALO
11.39
-0.47
-3.96%
ILMN
162.57
-0.27
-0.17%
INNV
0.21
0.00
0.00%
INO
6.98
-0.05
-0.71%
ISCO
1.03
+0.01
+0.98%
ISIS
0
0.00
0.00%
LGND
105.62
-0.79
-0.74%
LPTN
2.93
0.00
0.00%
MBVX
3.35
-0.01
-0.29%
MEIP
1.51
+0.04
+2.72%
MNOV
6.22
+0.03
+0.48%
MRTX
5.4
-0.05
-0.92%
MSTX
0.137
-0.003
-1.9313%
NBIX
42.25
+1.14
+2.77%
NUVA
70.35
+0.46
+0.66%
ONCS
1.36
+0.05
+3.82%
ONVO
3.7
+0.03
+0.82%
OREX
3.33
-0.06
-1.77%
OTIC
16.75
+0.15
+0.90%
QDEL
19.93
-0.08
-0.40%
RCPT
0
0.00
0.00%
RGLS
2.45
-0.05
-2.00%
RMD
65.33
+1.07
+1.67%
SCIE
0.002
+0.00
+25.0000%
SPHS
2.88
+0.09
+3.23%
SRNE
5.65
+0.15
+2.73%
TROV
2.4
+0.05
+2.13%
VICL
2.321
+0.011
+0.4935%
ZGNX
10.35
-1.15
-10.00%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.

Be Sociable, Share!